Merck & Co Inc
NYSE: MRK
$99.74
+$0.09 (+0.1%)
Real Time Data Delayed 15 Min.
MRK Articles
ThinkstockDrug giant Pfizer Inc. (NYSE: PFE) this morning reported adjusted earnings and revenues that missed analysts estimates, and the stock is down more than 3%. Last week competitor Amgen Inc....
Published:
Last Updated:
This week should mark the climax of first quarter corporate earnings season. It will be a full week for the earnings calendar, along with key economic events and some corporate annual meetings to...
Published:
Last Updated:
While the current stock market rally has been impressive since the lows last November, many investors, analysts and equity strategists are casting a wary eye at the looming May 1 date. In a new...
Published:
Last Updated:
Jon OggShort sellers have increased their bets against some of the defensive high-yield dividend stocks, while paring down in others. As you will see, the dividend and stock performance matter here....
Published:
ThinkstockWith the markets making new highs seemingly every day, it is understandable that investors may be finding it harder and harder to find stocks that do not appear overvalued, or at a minimum...
Published:
Jon OggShort sellers may be getting smarter about all the inflows of capital heading into dividend stocks. The short interest fell in many of the names, but investors should understand that this...
Published:
Jon Ogg24/7 Wall St. wants some insight from readers ahead of earnings season. We have grouped four rival sectors to see which ones investors are more excited about this earnings season. This is a...
Published:
Last Updated:
ThinkstockAccording to the Center for Disease Control (CDC), more than one-third (35.7%) of all adults in the United States are obese. Obesity-related medical conditions include heart attack, stroke,...
Published:
Jon OggShort sellers have kept their attack up against the high-dividend stocks, perhaps indicating that many investors believe that the bull market may turn back toward growth rather than paying a...
Published:
Jon OggShort sellers have continued to by and large increase their short-sale bets against the quality high-yield dividend stocks. The price gains must lead short sellers to believe that the yields...
Published:
U.S. equity markets opened lower this morning following news out of China that government is about to tighten restrictions on real estate transactions. The news pushed the Shanghai exchange down...
Published:
Last Updated:
Jon OggThese are some of this Monday’s top analyst upgrades, downgrades and initiations seen from Wall St. research calls. AMAG Pharmaceuticals Inc. (NASDAQ: AMAG) raised to Neutral at J.P....
Published:
Last Updated:
Jon OggShort sellers have increased their bets by and large against our universe of go-to quality dividend stocks. We tracked the short interest changes from the February 15 settlement date, versus...
Published:
Jon OggShort sellers have had their challenges due to rising share prices since the start of 2013. They have gone on to make some serious changes in the high dividend stocks now that the dividend tax...
Published:
ThinkstockInvesting in biotech or biopharmaceutical stocks can prove to be a very daunting task. Many of the stocks have limited pipelines or their very survival depends on a single binary event that...
Published:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.